Why is JSS a strategic partner for your COVID-19 study development?

JSS COVID-19 Task Force

  • We have designated a team which keeps abreast of the latest developments pertaining to SARS-CoV-2

  • We have a deep understanding and are fully aware of the challenges involved in the current treatment processes and testing protocols according to the regulations of various states and provinces

  • Scientific Affairs Group
    • COVID-19 Standard of Care and Competing Studies
    • COVID-19 Synopsis and Protocol Templates

  • Feasibility
    • We are securing potential sites
    • We are remaining up-to-date with changing patient availability
    • We are aware of differentiations between Hospitals (Canada vs US), CHSLDs, Long-Term Care facilities and SMOs

Medical device companies, like their biotech counterparts face the challenge of access to capital in order to fund their clinical development programs. In addition they face stringent regulatory requirements and a need to demonstrate real world evidence of clinical benefit in order to obtain reimbursement from Payors.

JSS Medical Research possesses the experience and expertise to assist medical device companies with both pre-approval (pilot and pivotal) and post approval studies. We have experience with device studies in the following therapeutic areas :

• Gastric surgery
• Respiratory
• Wound care
• Surgical intervention
• Trauma
• Endocrinology

We have provided clinical trial and outcomes research support to small private medical device companies as well as large multinational organizations and universities.